Case number 1:22-cv-01055
ZS Pharma, Inc. et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Main Document) (19) |
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 48-56) (30) |
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 41-47) (30) |
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 29-40) (30) |
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 23-28) (30) |
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 22) (30) |
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 21) (30) |
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 11-20) (30) |
| Jun 30, 2023 | 51 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 1-10) (30) |
| Jun 30, 2023 | 50 | NOTICE OF SERVICE of (1) Plaintiff's Objections and Responses to Defendants' First Set of Common Interrogatories, and (2) Plaintiffs' Objections and Responses to Defendants' First Set of Common Requests for Production filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 06/30/2023) (6) |
| Jun 27, 2023 | 49 | NOTICE OF SERVICE of Lupin's Supplemental Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Supplemental Initial Disclosures Pursuant to Rule 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 06/27/2023) (2) |
| Jun 26, 2023 | 48 | STIPULATION TO EXTEND TIME the Deadline to Submit a Joint Technology Tutorial to November 3, 2023 - filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 06/26/2023) (4) |
| Jun 5, 2023 | 47 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Common Interrogatories (Nos. 1-5) to Defendants, (2) Plaintiffs' First Individual Interrogatory (No. 1) to Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc., and (3) Plaintiffs' First Individual Interrogatory (No. 1) to Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 06/05/2023) (6) |
| Jun 2, 2023 | 46 | NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms for Construction filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 06/02/2023) (6) |
| Jun 2, 2023 | 45 | NOTICE OF SERVICE of Defendants' Disclosure of Claim Terms and Proposed Constructions filed by Sandoz Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 06/02/2023) (3) |
| May 30, 2023 | 44 | NOTICE OF SERVICE of Defendants' First Set of Common Requests for Production of Documents and Things (Nos. 1-90) and Defendants' First Set of Common Interrogatories (Nos. 1-10) filed by Sandoz Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 05/30/2023) (3) |
| Apr 21, 2023 | 43 | Letter to The Honorable Gregory B. Williams from John C. Phillips, Jr. regarding Request to Schedule a Discovery Teleconference. (Phillips, John) (Entered: 04/21/2023) (2) |
| Mar 31, 2023 | 42 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions with Claim Charts filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 03/31/2023) (6) |
| Mar 3, 2023 | 41 | NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiffs' Second Set of Requests (Nos. 11-47) to Defendants for the Production of Documents and Things filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 03/03/2023) (2) |
| Mar 3, 2023 | 40 | MOTION for Pro Hac Vice Appearance of Attorney Ashley Graham - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Ashley Graham)(Bilson, David) (Entered: 03/03/2023) (Main Document) (1) |
| Mar 3, 2023 | 40 | MOTION for Pro Hac Vice Appearance of Attorney Ashley Graham - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Ashley Graham)(Bilson, David) (Entered: 03/03/2023) (Certification of Ashley Graham) (1) |
| Feb 2, 2023 | 39 | PROPOSED ORDER Stipulated Protective Order by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Silver, Daniel) (Entered: 02/02/2023) (30) |
| Feb 1, 2023 | 38 | NOTICE OF SERVICE of Plaintiffs' Second Set of Requests (Nos. 11-47) to Defendants for the Production of Documents and Things filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 02/01/2023) (6) |
| Jan 26, 2023 | 37 | STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to February 2, 2023 - filed by ZS Pharma, Inc., AstraZeneca Pharmaceuticals, LP. (Joyce, Alexandra) (Entered: 01/26/2023) (3) |
| Jan 20, 2023 | 36 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants Accused Products and Plaintiffs' Asserted Patents filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 01/20/2023) (7) |
| Jan 20, 2023 | 35 | NOTICE OF SERVICE of Lupin's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 01/20/2023) (2) |
| Jan 19, 2023 | 34 | STIPULATION Stipulation and [Proposed] Order to Extend Time to Submit Proposed Protective Order by Sandoz Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) (Entered: 01/19/2023) (3) |
| Jan 19, 2023 | 33 | NOTICE OF SERVICE of Plaintiffs ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP's Paragraph 3 Disclosures filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Silver, Daniel) (Entered: 01/19/2023) (6) |
| Jan 13, 2023 | 32 | NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiffs' First Set of Requests (Nos. 1-10) to Defendants for the Production of Documents and Things filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 01/13/2023) (2) |
| Jan 12, 2023 | 31 | NOTICE OF SERVICE of Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 01/12/2023) (2) |
| Jan 12, 2023 | 30 | NOTICE OF SERVICE of Plaintiffs ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP's Rule 26(a)(1) Initial Disclosures filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 01/12/2023) (6) |
| Jan 9, 2023 | 29 | Official Transcript of Teleconference held on 12/12/2022 before Judge Gregory B. Williams. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/30/2023. Redacted Transcript Deadline set for 2/9/2023. Release of Transcript Restriction set for 4/10/2023. (dh) (Entered: 01/09/2023) (6) |
| Dec 29, 2022 | 28 | SCHEDULING ORDER: Fact Discovery completed by 6/14/2024. Status Report due by 2/16/2024. Joint Claim Construction Brief due by 11/10/2023. A Markman Hearing is set for 12/7/2023 at 02:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 2/27/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-day Bench Trial is set for 3/10/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 12/29/22. Associated Cases: 1:22-cv-01055-GBW, 1:22-cv-01096-GBW, 1:22-cv-01099-GBW, 1:22-cv-01100-GBW, 1:22-cv-01101-GBW (ntl) (Entered: 12/29/2022) (21) |
| Dec 15, 2022 | 27 | PROPOSED ORDER Scheduling (Amended) by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 12/15/2022) (21) |
| Dec 14, 2022 | 26 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests (Nos. 1-10) to Defendant for the Production of Documents and Things filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc..(Joyce, Alexandra) (Entered: 12/14/2022) (2) |
| Dec 12, 2022 | 25 | MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene - filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc.. (Silver, Daniel) (Entered: 12/12/2022) (4) |
| Dec 6, 2022 | 24 | ORAL ORDER: Having reviewed the parties' proposed scheduling order for the coordinated cases 22-cv-1055, 22-cv-1096, 22-cv-1099, 22-cv-1100, and 22-1101, a Rule 16 telephonic conference will be held on Monday, December 12, 2022 at 11:00 a.m. The parties shall arrange for the teleconference and shall provide chambers with the call-in information. ORDERED by Judge Gregory B. Williams on 12/6/22. Associated Cases: 1:22-cv-01055-GBW, 1:22-cv-01096-GBW, 1:22-cv-01099-GBW, 1:22-cv-01100-GBW, 1:22-cv-01101-GBW (ntl) (Entered: 12/06/2022) (0) |
| Dec 2, 2022 | 23 | Letter to The Honorable Gregory B. Williams from Alexandra M. Joyce, Esq. regarding Scheduling Order. (Attachments: # 1 Proposed Rule 16 Scheduling Order)(Joyce, Alexandra) (Entered: 12/02/2022) (Proposed Rule 16 Scheduling Order) (20) |
| Dec 2, 2022 | 23 | Letter to The Honorable Gregory B. Williams from Alexandra M. Joyce, Esq. regarding Scheduling Order. (Attachments: # 1 Proposed Rule 16 Scheduling Order)(Joyce, Alexandra) (Entered: 12/02/2022) (Main Document) (1) |
| Nov 23, 2022 | 22 | STIPULATION TO EXTEND TIME to meet and confer and submit a joint proposed scheduling order to December 2, 2022 - filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 11/23/2022) (4) |
| Oct 21, 2022 | 21 | ANSWER to 19 Answer to Amended Complaint, Counterclaim of Lupin Limited and Lupin Pharmaceuticals, Inc. by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc..(Silver, Daniel) (Entered: 10/21/2022) (30) |
| Oct 17, 2022 | 20 | STIPULATION and [Proposed] Order Regarding Case Coordination and Extension of Deadline for Case Schedule by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 10/17/2022) (5) |
| Oct 7, 2022 | 19 | ANSWER to Amended Complaint, re: 16 Amended Complaint Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Limited.(Bilson, David) (Entered: 10/07/2022) (30) |
| Oct 4, 2022 | 18 | ORAL ORDER IT IS HEREBY ORDERED that, not later than thirty (30) days from the date of this Order, the parties shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (see Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Scheduling Conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order which those appear. ORDERED by Judge Gregory B. Williams on 10/4/22. Associated Cases: 1:22-cv-01101-GBW, 1:22-cv-01055-GBW, 1:22-cv-01099-GBW (ntl) (Entered: 10/04/2022) (0) |
| Sep 23, 2022 | 17 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,406,662 REVISED. (Silver, Daniel) (Entered: 09/23/2022) (3) |
| Sep 23, 2022 | 16 | Amended Complaint* (1) |
| Aug 10, 2022 | 1 | Complaint* (1) |
